RespireRx Pharmaceuticals Inc. 4
4 · RespireRx Pharmaceuticals Inc. · Filed Jan 20, 2017
Insider Transaction Report
Form 4
WEINGARTEN ROBERT N
DirectorVice President and CFO
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2017-01-18+50,000→ 50,000 totalExercise: $3.90Exp: 2022-01-18→ Common Stock (50,000 underlying)
Holdings
- 73,847
Common Stock Options (to purchase shares of Common Stock)
Exercise: $7.38Exp: 2021-03-31→ Common Stock (73,847 underlying) - 46,154
Common Stock Options (to purchase shares of Common Stock)
Exercise: $8.13Exp: 2022-06-30→ Common Stock (46,154 underlying) - 30,770
Common Stock Options (to purchase shares of Common Stock)
Exercise: $6.40Exp: 2022-08-18→ Common Stock (30,770 underlying) - 15,385
Common Stock Options (to purchase shares of Common Stock)
Exercise: $16.25Exp: 2019-07-17→ Common Stock (15,385 underlying)
Footnotes (6)
- [F1]These Common Stock Options vest in three installments: 25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017.
- [F2]The exercise price and number of shares of these securities have been adjusted to reflect the Company's 325-to-1 reverse stock split effective September 1, 2016.
- [F3]These Common Stock Options vested in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016, and are all currently vested and exercisable.
- [F4]These Common Stock Options vested in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016, and are all currently vested and exercisable.
- [F5]These Common Stock Options vest in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015, and are all currently vested and exercisable.
- [F6]These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested and exercisable.